Similar articles

• HIV infection and subclinical coronary atherosclerosis.

  Post WS, George RT, Budoff M. Post WS, et al. Ann Intern Med. 2014 Dec 16;161(12):923-4. doi: 10.7326/L14-5033-2. Ann Intern Med. 2014. PMID: 25506861 No abstract available.
• A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study.

  McKibben RA, Haberlen SA, Post WS, Brown TT, Budoff M, Witt MD, Kingsley LA, Palella FJ Jr, Thio CL, Seaberg EC. McKibben RA, et al. J Infect Dis. 2016 Jan 15;213(2):257-65. doi: 10.1093/infdis/jiv396. Epub 2015 Jul 27. J Infect Dis. 2016. PMID: 26216904 Free PMC article.
• Immune activation and coronary atherosclerosis in HIV-infected women: where are we now, and where will we go next?

  Boccara F, Cohen A. Boccara F, et al. J Infect Dis. 2013 Dec 1;208(11):1729-31. doi: 10.1093/infdis/jit511. Epub 2013 Sep 16. J Infect Dis. 2013. PMID: 24041798 No abstract available.
• Accelerated coronary atherosclerosis after execution of percutaneous coronary intervention in patient with HIV/HCV coinfection: case report and review of the literature.

  Ceccarelli G, d'Ettorre G, Mancone M, Francone M, Vullo V. Ceccarelli G, et al. Cardiovasc Revasc Med. 2011 Jul-Aug;12(4):262-5. doi: 10.1016/j.carrev.2010.11.006. Epub 2011 Jan 26. Cardiovasc Revasc Med. 2011. PMID: 21273145 Review.
• Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.

  Ampuero J, Gallego-Durán R, Romero-Gómez M. Ampuero J, et al. Rev Esp Enferm Dig. 2015 Jan;107(1):10-6. Rev Esp Enferm Dig. 2015. PMID: 25603326 Review.